• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

将弹性张量和PC-SAFT建模与基于系统的制药4.0模拟相结合,以预测三元纳米晶悬浮液的工艺操作和产品规格。

Integrating Elastic Tensor and PC-SAFT Modeling with Systems-Based Pharma 4.0 Simulation, to Predict Process Operations and Product Specifications of Ternary Nanocrystalline Suspensions.

作者信息

Ouranidis Andreas, Davidopoulou Christina, Kachrimanis Kyriakos

机构信息

Department of Pharmaceutical Technology, School of Pharmacy, Aristotle University of Thessaloniki, 54124 Thessaloniki, Greece.

Department of Chemical Engineering, Aristotle University of Thessaloniki, 54124 Thessaloniki, Greece.

出版信息

Pharmaceutics. 2021 Oct 22;13(11):1771. doi: 10.3390/pharmaceutics13111771.

DOI:10.3390/pharmaceutics13111771
PMID:34834186
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8623873/
Abstract

Comminution of BCS II APIs below the 1 μm threshold followed by solidification of the obtained nanosuspensions improves their dissolution properties. The breakage process reveals new crystal faces, thus creating altered crystal habits of improved wettability, facilitated by the adsorption of stabilizing polymers. However, process-induced transformations remain unpredictable, mirroring the current limitations of our atomistic level of understanding. Moreover, conventional equations of estimating dissolution, such as Noyes-Whitney and Nernst-Brunner, are not suitable to quantify the solubility enhancement due to the nanoparticle formation; hence, neither the complex stabilizer contribution nor the adsorption influence on the interfacial tension occurring between the water and APIs is accounted for. For such ternary mixtures, no numeric method exists to correlate the mechanical properties with the interfacial energy, capable of informing the key process parameters and the thermodynamic stability assessment of nanosuspensions. In this work, an elastic tensor analysis was performed to quantify the API stability during process implementation. Moreover, a novel thermodynamic model, described by the stabilizer-coated nanoparticle Gibbs energy anisotropic minimization, was structured to predict the material's system solubility quantified by the application of PC-SAFT modeling. Comprehensively merging elastic tensor and PC-SAFT analysis into the systems-based Pharma 4.0 algorithm provided a validated, multi-level, built-in method capable of predicting the critical material quality attributes and corresponding key process parameters.

摘要

将BCS II类活性药物成分粉碎至1μm阈值以下,随后将所得纳米混悬液固化,可改善其溶解性能。破碎过程会暴露出新的晶面,从而形成润湿性得到改善的改变后的晶体习性,这得益于稳定聚合物的吸附。然而,过程诱导的转变仍然不可预测,反映了我们在原子水平理解上的当前局限性。此外,传统的溶解估算方程,如Noyes-Whitney方程和Nernst-Brunner方程,不适用于量化由于纳米颗粒形成而导致的溶解度增强;因此,既没有考虑复合稳定剂的作用,也没有考虑吸附对水与活性药物成分之间界面张力的影响。对于这种三元混合物,不存在将机械性能与界面能相关联的数值方法,而这种方法能够告知纳米混悬液的关键工艺参数和热力学稳定性评估。在这项工作中,进行了弹性张量分析以量化工艺实施过程中活性药物成分的稳定性。此外,构建了一种新颖的热力学模型,该模型由稳定剂包覆的纳米颗粒吉布斯能量各向异性最小化描述,以预测通过应用PC-SAFT模型量化的材料系统溶解度。将弹性张量和PC-SAFT分析全面整合到基于系统的制药4.0算法中,提供了一种经过验证的、多层次的内置方法,能够预测关键材料质量属性和相应的关键工艺参数。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5257/8623873/8b99bb908e43/pharmaceutics-13-01771-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5257/8623873/d6374c3e2a56/pharmaceutics-13-01771-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5257/8623873/dfb6b279d935/pharmaceutics-13-01771-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5257/8623873/0f298cb8ab92/pharmaceutics-13-01771-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5257/8623873/88477aa33175/pharmaceutics-13-01771-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5257/8623873/154b7ee64b20/pharmaceutics-13-01771-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5257/8623873/a9511ccd8cfc/pharmaceutics-13-01771-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5257/8623873/8eab8881ee9b/pharmaceutics-13-01771-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5257/8623873/95534c3f6827/pharmaceutics-13-01771-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5257/8623873/8b99bb908e43/pharmaceutics-13-01771-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5257/8623873/d6374c3e2a56/pharmaceutics-13-01771-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5257/8623873/dfb6b279d935/pharmaceutics-13-01771-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5257/8623873/0f298cb8ab92/pharmaceutics-13-01771-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5257/8623873/88477aa33175/pharmaceutics-13-01771-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5257/8623873/154b7ee64b20/pharmaceutics-13-01771-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5257/8623873/a9511ccd8cfc/pharmaceutics-13-01771-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5257/8623873/8eab8881ee9b/pharmaceutics-13-01771-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5257/8623873/95534c3f6827/pharmaceutics-13-01771-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5257/8623873/8b99bb908e43/pharmaceutics-13-01771-g009.jpg

相似文献

1
Integrating Elastic Tensor and PC-SAFT Modeling with Systems-Based Pharma 4.0 Simulation, to Predict Process Operations and Product Specifications of Ternary Nanocrystalline Suspensions.将弹性张量和PC-SAFT建模与基于系统的制药4.0模拟相结合,以预测三元纳米晶悬浮液的工艺操作和产品规格。
Pharmaceutics. 2021 Oct 22;13(11):1771. doi: 10.3390/pharmaceutics13111771.
2
Pharma 4.0-Artificially Intelligent Digital Twins for Solidified Nanosuspensions.制药4.0——用于固化纳米混悬液的人工智能数字孪生体
Pharmaceutics. 2022 Oct 3;14(10):2113. doi: 10.3390/pharmaceutics14102113.
3
Application of PC-SAFT EOS for Pharmaceuticals: Solubility, Co-Crystal, and Thermodynamic Modeling.PC-SAFT EOS 在药物学中的应用:溶解度、共晶和热力学建模。
J Pharm Sci. 2021 Jun;110(6):2442-2451. doi: 10.1016/j.xphs.2020.12.035. Epub 2021 Jan 5.
4
Solvent influence on the phase behavior and glass transition of Amorphous Solid Dispersions.溶剂对无定形固体分散体的相行为和玻璃化转变的影响。
Eur J Pharm Biopharm. 2021 Jan;158:132-142. doi: 10.1016/j.ejpb.2020.11.002. Epub 2020 Nov 16.
5
Long-Term Physical Stability of PVP- and PVPVA-Amorphous Solid Dispersions.聚乙烯吡咯烷酮和聚乙烯吡咯烷酮-醋酸乙烯酯无定形固体分散体的长期物理稳定性
Mol Pharm. 2017 Jan 3;14(1):157-171. doi: 10.1021/acs.molpharmaceut.6b00763. Epub 2016 Dec 7.
6
Thermodynamic Modeling of Solvent-Impact on Phase Separation in Amorphous Solid Dispersions during Drying.干燥过程中无定形固体分散体中溶剂影响相分离的热力学建模。
Mol Pharm. 2020 Jul 6;17(7):2721-2733. doi: 10.1021/acs.molpharmaceut.0c00418. Epub 2020 Jun 16.
7
D-Alpha-tocopherol acid polyethylene glycol 1000 succinate, an effective stabilizer during solidification transformation of baicalin nanosuspensions.D-α-生育酚聚乙二醇 1000 琥珀酸酯,黄芩苷纳米混悬液固化相变过程中的有效稳定剂。
Int J Pharm. 2013 Feb 25;443(1-2):279-87. doi: 10.1016/j.ijpharm.2012.12.036. Epub 2013 Jan 3.
8
Predicting the Solubility Advantage of Amorphous Pharmaceuticals: A Novel Thermodynamic Approach.预测无定形药物的溶解性优势:一种新颖的热力学方法。
Mol Pharm. 2015 Aug 3;12(8):2823-33. doi: 10.1021/mp500824d. Epub 2015 Jul 8.
9
Predicting process design spaces for spray drying amorphous solid dispersions.预测喷雾干燥无定形固体分散体的工艺设计空间。
Int J Pharm X. 2021 Feb 25;3:100072. doi: 10.1016/j.ijpx.2021.100072. eCollection 2021 Dec.
10
Influence of Low-Molecular-Weight Excipients on the Phase Behavior of PVPVA64 Amorphous Solid Dispersions.低分子量辅料对 PVPVA64 无定形固体分散体相行为的影响。
Pharm Res. 2018 Jan 5;35(1):25. doi: 10.1007/s11095-017-2316-y.

引用本文的文献

1
COMPARING vaccine manufacturing technologies recombinant DNA vs in vitro transcribed (IVT) mRNA.比较疫苗制造技术:重组 DNA 与体外转录(IVT)mRNA。
Sci Rep. 2024 Sep 18;14(1):21742. doi: 10.1038/s41598-024-67797-x.
2
Pharma 4.0-Artificially Intelligent Digital Twins for Solidified Nanosuspensions.制药4.0——用于固化纳米混悬液的人工智能数字孪生体
Pharmaceutics. 2022 Oct 3;14(10):2113. doi: 10.3390/pharmaceutics14102113.
3
mRNA Therapeutic Modalities Design, Formulation and Manufacturing under Pharma 4.0 Principles.基于制药4.0原则的mRNA治疗方式的设计、制剂与生产

本文引用的文献

1
Predicting process design spaces for spray drying amorphous solid dispersions.预测喷雾干燥无定形固体分散体的工艺设计空间。
Int J Pharm X. 2021 Feb 25;3:100072. doi: 10.1016/j.ijpx.2021.100072. eCollection 2021 Dec.
2
Nanosuspensions and Microneedles Roller as a Combined Approach to Enhance Diclofenac Topical Bioavailability.纳米混悬剂与微针滚刺相结合提高双氯芬酸局部生物利用度的方法
Pharmaceutics. 2020 Nov 25;12(12):1140. doi: 10.3390/pharmaceutics12121140.
3
Overcoming the Solubility Barrier of Ibuprofen by the Rational Process Design of a Nanocrystal Formulation.
Biomedicines. 2021 Dec 27;10(1):50. doi: 10.3390/biomedicines10010050.
通过纳米晶体制剂的合理工艺设计克服布洛芬的溶解度障碍
Pharmaceutics. 2020 Oct 14;12(10):969. doi: 10.3390/pharmaceutics12100969.
4
Physical stability of hydroxypropyl methylcellulose-based amorphous solid dispersions: Experimental and computational study.基于羟丙基甲基纤维素的无定形固体分散体的物理稳定性:实验和计算研究。
Int J Pharm. 2020 Nov 15;589:119845. doi: 10.1016/j.ijpharm.2020.119845. Epub 2020 Sep 12.
5
Intrinsic Dissolution Rate Profiling of Poorly Water-Soluble Compounds in Biorelevant Dissolution Media.难溶性化合物在生物相关溶出介质中的固有溶出速率分析
Pharmaceutics. 2020 May 28;12(6):493. doi: 10.3390/pharmaceutics12060493.
6
Computational Fluid Dynamics (CFD) Simulations of Spray Drying: Linking Drying Parameters with Experimental Aerosolization Performance.喷雾干燥的计算流体动力学(CFD)模拟:将干燥参数与实验气溶胶性能联系起来。
Pharm Res. 2020 May 21;37(6):101. doi: 10.1007/s11095-020-02806-y.
7
Solubility of pharmaceutical ingredients in triglycerides.药物成分在三酸甘油脂中的溶解度。
Eur J Pharm Biopharm. 2019 Dec;145:113-120. doi: 10.1016/j.ejpb.2019.10.012. Epub 2019 Nov 2.
8
Combination of NMR Methods To Reveal the Interfacial Structure of a Pharmaceutical Nanocrystal and Nanococrystal in the Suspended State.采用 NMR 方法组合揭示悬浮状态下药物纳米晶和纳米混悬剂的界面结构。
Mol Pharm. 2018 Sep 4;15(9):3901-3908. doi: 10.1021/acs.molpharmaceut.8b00360. Epub 2018 Aug 21.
9
Solid dissolution in a fluid solvent is characterized by the interplay of surface area-dependent diffusion and physical fragmentation.固体在流体溶剂中的溶解过程的特点是表面积相关的扩散和物理碎裂的相互作用。
Sci Rep. 2018 May 16;8(1):7711. doi: 10.1038/s41598-018-25821-x.
10
Influences of Crystal Anisotropy in Pharmaceutical Process Development.药物晶型工艺开发中的各向异性影响。
Pharm Res. 2018 Mar 19;35(5):100. doi: 10.1007/s11095-018-2374-9.